Who We Are

As pioneers in clinical genetics, Genetic Technologies has spent the past 20 years decoding the genome and unlocking its value for human health. 


Under our geneType product series, our clinicians, scientists and technicians are working to develop the next generation of integrated predictive genetic testing and assessment tools – empowering physicians and patients to proactively manage health.

A Leader in Personalised Predictive Genetics

GeneType Integrated Risk, Polygenic Risk (PRS) and Clinical Risk (CRS)*

*Tests can only be ordered by medical practitioners

Inherited Monogenic Disease (Germline)

Carrier Testing

Non-invasive Prenatal Testing

Pharmacogenetic Testing

DNA Testing (Ancestry, Paternity)

Intolerance Test

PetgenTM Animal Test

DNA Storage

What We Stand For

These are more than just words on a page. Our team, from the top down, makes a conscious decision to integrate our company values into our decision making and practices.

Unequalled experience

20+ years of experience, tracing back to the human genome project.

Relentless innovation

Accelerating the world’s transition to gene-based healthcare.

Leading integrated technology

A more complete picture of disease risk, incorporating genetic & clinical risk factors.

Setting new standards

Setting clinical, safety and ethical standards to ensure the best health outcomes.

Unequalled Experience

Leaders in breast and colorectal cancer integrated risk assessment, geneType continues to expand our clinical-grade assessments into new cancers and chronic conditions.

We are evolving modern medicine to meet clinical needs.

Leading Integrated Technology

Our personalised risk assessments provide a more complete picture, incorporating polygenic and clinical risk factors in one comprehensive assessment.

We lead the way in clinical integration of polygenic risk by creating proprietary algorithms that are specifically calibrated to the general population. All of our disease-specific tests outperform their respective clinical gold-standard risk models.

Our technology is designed to provide clinicians with absolute risk scores that simplify the complex integration of risk factors and ultimately enable actionable recommendations.  

GeneType empowers individuals and their medical practitioners to adopt a personalised health approach to disease screening, risk-reduction and prevention.

Relentless Innovation

The human impact and potential applications for genetic integration into clinical care are immense. 

GeneType are at the forefront of the genetic revolution – expanding our pipeline of clinical risk assessment products to a broader range of cancers and chronic conditions. 

We’re collaborating alongside leading medical practitioners globally, through our advisory board, to democratise genomics. Leveraging technology, software and processes to make integrated preventative genetics an integral part of modern medicine.  We’re working hard to deliver a more efficient, integrated and personalised model of care.

Accelerating the world’s transition to genomic-integrated healthcare.

Setting New Standards

As trusted leaders, we have a role to play in managing quality and impact of genomics on the future of medicine and health.  

GeneType delivers the highest standards of accuracy with our medical grade tests. And we safeguard the privacy and security of personal health data, ensuring people have full control of their genetic information.

We ensure every test comes with actionable outcomes in conjunction with medical practitioners. We provide clear next steps, supporting individuals to interpret results. 

We’re setting clinical, safety and ethical standards to ensure the best health outcomes.

GeneType Blog